Asahi Kasei Pharma America Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 19

Employees

  • Latest Deal Type
  • M&A

Asahi Kasei Pharma America General Information

Description

Provider of critical-care and hospital-based therapeutics to patients, treating physicians, and payors in the United States and internationally. The company offers ART-123, a novel, recombinant, and soluble thrombomodulin for the treatment of disseminated intravascular coagulation in sepsis.

Contact Information

Formerly Known As
Artisan Pharma, Artisan Therapeutics, Artisan Therapeutics Inc
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 200 Fifth Avenue
  • 6th Floor
  • Waltham, MA 02451
  • United States
+1 (781)
Primary Industry
Pharmaceuticals
Acquirer
Corporate Office
  • 200 Fifth Avenue
  • 6th Floor
  • Waltham, MA 02451
  • United States
+1 (781)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Asahi Kasei Pharma America Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 28-Nov-2011 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series C) 20-Jul-2010 Completed Startup
3. Early Stage VC (Series B) 01-Mar-2010 Completed Startup
2. Early Stage VC 20-Jan-2010 $15.4M $54.4M Completed Startup
1. Early Stage VC (Series A) 06-Sep-2006 $39M $39M Completed Startup
To view Asahi Kasei Pharma America’s complete valuation and funding history, request access »

Asahi Kasei Pharma America Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 22,000,000 $0.001000 6% $2 $2 1x $1.83 43.78%
To view Asahi Kasei Pharma America’s complete cap table history, request access »

Asahi Kasei Pharma America Patents

Asahi Kasei Pharma America Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240366505-A1 Liquid resin extended-release oral naltrexone formulation for treating autism-related disorders Pending 26-Jan-2022
US-20250134883-A1 Novel compositions Pending 26-Jan-2022

Asahi Kasei Pharma America Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Asahi Kasei Pharma America Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Asahi Kasei Corporate Venture Capital Corporate Venture Capital Minority
Bio*One Capital Corporate Venture Capital Minority
EDBI Venture Capital Minority
IQVIA Holdings Corporation Minority
Jafco Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Asahi Kasei Pharma America FAQs

  • When was Asahi Kasei Pharma America founded?

    Asahi Kasei Pharma America was founded in 2006.

  • Where is Asahi Kasei Pharma America headquartered?

    Asahi Kasei Pharma America is headquartered in Waltham, MA.

  • What is the size of Asahi Kasei Pharma America?

    Asahi Kasei Pharma America has 19 total employees.

  • What industry is Asahi Kasei Pharma America in?

    Asahi Kasei Pharma America’s primary industry is Pharmaceuticals.

  • Is Asahi Kasei Pharma America a private or public company?

    Asahi Kasei Pharma America is a Private company.

  • What is Asahi Kasei Pharma America’s current revenue?

    The current revenue for Asahi Kasei Pharma America is .

  • How much funding has Asahi Kasei Pharma America raised over time?

    Asahi Kasei Pharma America has raised $79.6M.

  • Who are Asahi Kasei Pharma America’s investors?

    Asahi Kasei Corporate Venture Capital, Bio*One Capital, EDBI, IQVIA Holdings, and Jafco are 5 of 7 investors who have invested in Asahi Kasei Pharma America.

  • When was Asahi Kasei Pharma America acquired?

    Asahi Kasei Pharma America was acquired on 28-Nov-2011.

  • Who acquired Asahi Kasei Pharma America?

    Asahi Kasei Pharma America was acquired by Asahi Kasei.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process